The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
STERIS plc's Score
Industry at a Glance
Industry Ranking
10 / 207
Overall Ranking
53 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
9
analysts
Buy
Current Rating
281.726
Target Price
+7.01%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
STERIS plc Highlights
StrengthsRisks
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.35% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 5.46B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 36.04%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 36.04%.
Undervalued
The company’s latest PE is 37.63, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 95.05M shares, decreasing 3.12% quarter-over-quarter.
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Ticker SymbolSTE
CompanySTERIS plc
CEOMr. Daniel A. Carestio
Websitehttps://www.steris.com/
FAQs
What is the current price of STERIS plc (STE)?
The current price of STERIS plc (STE) is 263.280.
What is the symbol of STERIS plc?
The ticker symbol of STERIS plc is STE.
What is the 52-week high of STERIS plc?
The 52-week high of STERIS plc is 268.600.
What is the 52-week low of STERIS plc?
The 52-week low of STERIS plc is 200.980.
What is the market capitalization of STERIS plc?
The market capitalization of STERIS plc is 25.83B.
What is the net income of STERIS plc?
The net income of STERIS plc is 614.64M.
Is STERIS plc (STE) currently rated as Buy, Hold, or Sell?
According to analysts, STERIS plc (STE) has an overall rating of Buy, with a price target of 281.726.
What is the Earnings Per Share (EPS TTM) of STERIS plc (STE)?
The Earnings Per Share (EPS TTM) of STERIS plc (STE) is 6.996.